TG Therapeutics (TGTX) Insider Trading & Ownership $29.55 +0.41 (+1.41%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TG Therapeutics (NASDAQ:TGTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.13 M Get TGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling TG Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TGTX Insider Buying and Selling by Quarter TG Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025Sean A PowerCFOSell10,021$28.53$285,899.13 1/3/2025Sean A PowerCFOSell11,337$30.29$343,397.73 11/11/2024Sagar LonialDirectorSell5,000$30.44$152,200.00 3/12/2024Laurence N CharneyDirectorSell22,000$15.97$351,340.00 (Data available from 1/1/2013 forward) TGTX Insider Trading Activity - Frequently Asked Questions Who is on TG Therapeutics's Insider Roster? The list of insiders at TG Therapeutics includes Laurence N Charney, Michael S Weiss, Sagar Lonial, Sean A Power, and Yann Echelard. Learn more on insiders at TGTX. What percentage of TG Therapeutics stock is owned by insiders? 10.50% of TG Therapeutics stock is owned by insiders. Learn more on TGTX's insider holdings. Which TG Therapeutics insiders have been buying company stock? The following insider purchased TGTX shares in the last 24 months: Michael S Weiss ($1,013,000.00). How much insider buying is happening at TG Therapeutics? Insiders have purchased a total of 100,000 TGTX shares in the last 24 months for a total of $1,013,000.00 bought. Which TG Therapeutics insiders have been selling company stock? The following insiders have sold TGTX shares in the last 24 months: Laurence N Charney ($684,365.00), Sagar Lonial ($966,737.98), and Sean A Power ($3,405,102.73). How much insider selling is happening at TG Therapeutics? Insiders have sold a total of 222,226 TG Therapeutics shares in the last 24 months for a total of $5,056,205.71 sold. TG Therapeutics Key ExecutivesMr. Michael S. Weiss Esq. (Age 58)Chairman, CEO & President Compensation: $1.97MMr. Sean A. Power CPA (Age 42)CFO, Corporate Secretary & Treasurer Compensation: $670.58k2 recent tradesJenna BoscoSenior Vice President of Corporate CommunicationsMr. Adam WaldmanChief Commercialization Officer More Insider Trading Tools from MarketBeat Related Companies Genmab A/S Insider Trades Viatris Insider Trades Intra-Cellular Therapies Insider Trades Summit Therapeutics Insider Trades Moderna Insider Trades Catalent Insider Trades Sarepta Therapeutics Insider Trades Vaxcyte Insider Trades Roivant Sciences Insider Trades Revolution Medicines Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:TGTX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TGTX Stock Alerts